Annovis Bio (ANVS) EPS (Basic) (2019 - 2026)
Annovis Bio (ANVS) posted EPS (Basic) of -$0.65 for Q1 2026, down 29.62% sequentially from -$0.5 in Q4 2025, and down 85.53% YoY from -$4.5 in Q1 2025.
Annovis Bio (ANVS) EPS (Basic) (2019 - 2026) Analysis & Trends
Annovis Bio has reported EPS (Basic) for 8 years, with the latest figure at -$0.65 in Q1 2026.
- Quarterly EPS (Basic) fell 85.53% year-over-year to -$0.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.52 (up 16.4% YoY) and the FY2025 annual result came in at -$1.45, up 36.21% from the prior year.
- EPS (Basic) eased to -$0.65 in Q1 2026 per ANVS's latest filing, from -$0.5 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.1 in Q1 2024 and troughed at -$2.46 in Q4 2023.
- A 5-year average of -$0.81 and a median of -$0.65 in 2026 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) surged 91.55% in 2024, then tumbled 249.2% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.95 in 2022, then plunged by 160.08% to -$2.46 in 2023, then jumped by 73.62% to -$0.65 in 2024, then grew by 22.71% to -$0.5 in 2025, then fell by 29.62% to -$0.65 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.65, -$0.5, and -$0.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Annovis Bio | 67.91 Mn | 67.91 Mn | - | -0.38 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.65 |
| Dec 31, 2025 | -0.50 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.33 |
| Mar 31, 2025 | -0.35 |
| Dec 31, 2024 | -0.65 |
| Sep 30, 2024 | -0.97 |
| Jun 30, 2024 | -0.44 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -2.46 |
| Sep 30, 2023 | -1.63 |
| Jun 30, 2023 | -1.07 |
| Mar 31, 2023 | -1.19 |
| Dec 31, 2022 | -0.95 |
| Sep 30, 2022 | -0.79 |
| Jun 30, 2022 | -0.73 |
| Mar 31, 2022 | -0.64 |
| Dec 31, 2021 | -0.78 |
| Sep 30, 2021 | -0.35 |
| Jun 30, 2021 | -0.34 |